Literature DB >> 22665497

The stress response mediator ATF3 represses androgen signaling by binding the androgen receptor.

Hongbo Wang1, Ming Jiang, Hongmei Cui, Mengqian Chen, Ralph Buttyan, Simon W Hayward, Tsonwin Hai, Zhengxin Wang, Chunhong Yan.   

Abstract

Activating transcription factor 3 (ATF3) is a common mediator of cellular stress response signaling and is often aberrantly expressed in prostate cancer. We report here that ATF3 can directly bind the androgen receptor (AR) and consequently repress AR-mediated gene expression. The ATF3-AR interaction requires the leucine zipper domain of ATF3 that independently binds the DNA-binding and ligand-binding domains of AR, and the interaction prevents AR from binding to cis-acting elements required for expression of androgen-dependent genes while inhibiting the AR N- and C-terminal interaction. The functional consequences of the loss of ATF3 expression include increased transcription of androgen-dependent genes in prostate cancer cells that correlates with increased ability to grow in low-androgen-containing medium and increased proliferative activity of the prostate epithelium in ATF3 knockout mice that is associated with prostatic hyperplasia. Our results thus demonstrate that ATF3 is a novel repressor of androgen signaling that can inhibit AR functions, allowing prostate cells to restore homeostasis and maintain integrity in the face of a broad spectrum of intrinsic and environmental insults.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22665497      PMCID: PMC3434546          DOI: 10.1128/MCB.00159-12

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  66 in total

1.  Activation function 2 in the human androgen receptor ligand binding domain mediates interdomain communication with the NH(2)-terminal domain.

Authors:  B He; J A Kemppainen; J J Voegel; H Gronemeyer; E M Wilson
Journal:  J Biol Chem       Date:  1999-12-24       Impact factor: 5.157

Review 2.  Nuclear-receptor ligands and ligand-binding domains.

Authors:  R V Weatherman; R J Fletterick; T S Scanlan
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

3.  Androgen-insensitivity syndrome as a possible coactivator disease.

Authors:  M Adachi; R Takayanagi; A Tomura; K Imasaki; S Kato; K Goto; T Yanase; S Ikuyama; H Nawata
Journal:  N Engl J Med       Date:  2000-09-21       Impact factor: 91.245

4.  Androgen receptor gene expression in prostate cancer is directly suppressed by the androgen receptor through recruitment of lysine-specific demethylase 1.

Authors:  Changmeng Cai; Housheng Hansen He; Sen Chen; Ilsa Coleman; Hongyun Wang; Zi Fang; Shaoyong Chen; Peter S Nelson; X Shirley Liu; Myles Brown; Steven P Balk
Journal:  Cancer Cell       Date:  2011-10-18       Impact factor: 31.743

Review 5.  Cellular stress response pathways and ageing: intricate molecular relationships.

Authors:  Nikos Kourtis; Nektarios Tavernarakis
Journal:  EMBO J       Date:  2011-05-17       Impact factor: 11.598

6.  A small composite probasin promoter confers high levels of prostate-specific gene expression through regulation by androgens and glucocorticoids in vitro and in vivo.

Authors:  J Zhang; T Z Thomas; S Kasper; R J Matusik
Journal:  Endocrinology       Date:  2000-12       Impact factor: 4.736

Review 7.  The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis.

Authors:  T Hai; M G Hartman
Journal:  Gene       Date:  2001-07-25       Impact factor: 3.688

Review 8.  Molecular basis of androgen insensitivity.

Authors:  A O Brinkmann
Journal:  Mol Cell Endocrinol       Date:  2001-06-20       Impact factor: 4.102

9.  FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor.

Authors:  B He; J A Kemppainen; E M Wilson
Journal:  J Biol Chem       Date:  2000-07-28       Impact factor: 5.157

10.  KiSS-1 represses 92-kDa type IV collagenase expression by down-regulating NF-kappa B binding to the promoter as a consequence of Ikappa Balpha -induced block of p65/p50 nuclear translocation.

Authors:  C Yan; H Wang; D D Boyd
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

View more
  20 in total

1.  Inhibition of gastric tumor growth by a novel Hsp90 inhibitor.

Authors:  Chunwan Lu; Di Liu; Jing Jin; Hemantkumar Deokar; Yi Zhang; John K Buolamwini; Xiaoming Yu; Chunhong Yan; Xiaoguang Chen
Journal:  Biochem Pharmacol       Date:  2013-02-13       Impact factor: 5.858

2.  Activating transcription factor 3 interferes with p21 activation in histone deacetylase inhibitor-induced growth inhibition of epidermoid carcinoma cells.

Authors:  Zhen-Feng Hao; You-Ming Su; Cong-min Wang; Rong-Ya Yang
Journal:  Tumour Biol       Date:  2014-11-05

3.  The activating transcription factor 3 protein suppresses the oncogenic function of mutant p53 proteins.

Authors:  Saisai Wei; Hongbo Wang; Chunwan Lu; Sarah Malmut; Jianqiao Zhang; Shumei Ren; Guohua Yu; Wei Wang; Dale D Tang; Chunhong Yan
Journal:  J Biol Chem       Date:  2014-02-19       Impact factor: 5.157

4.  The Stress-responsive Gene ATF3 Mediates Dichotomous UV Responses by Regulating the Tip60 and p53 Proteins.

Authors:  Hongmei Cui; Xingyao Li; Chunhua Han; Qi-En Wang; Hongbo Wang; Han-Fei Ding; Junran Zhang; Chunhong Yan
Journal:  J Biol Chem       Date:  2016-03-18       Impact factor: 5.157

5.  Edelfosine Promotes Apoptosis in Androgen-Deprived Prostate Tumors by Increasing ATF3 and Inhibiting Androgen Receptor Activity.

Authors:  Thirupandiyur S Udayakumar; Radka Stoyanova; Mohammed M Shareef; Zhaomei Mu; Sakhi Philip; Kerry L Burnstein; Alan Pollack
Journal:  Mol Cancer Ther       Date:  2016-03-04       Impact factor: 6.261

6.  Expression array analysis of the hepatocyte growth factor invasive program.

Authors:  Fabiola Cecchi; Chih-Jian Lih; Young H Lee; William Walsh; Daniel C Rabe; Paul M Williams; Donald P Bottaro
Journal:  Clin Exp Metastasis       Date:  2015-08-01       Impact factor: 5.150

7.  ONC201 Targets AR and AR-V7 Signaling, Reduces PSA, and Synergizes with Everolimus in Prostate Cancer.

Authors:  Avital Lev; Amriti R Lulla; Brian C Ross; Marie D Ralff; Petr B Makhov; David T Dicker; Wafik S El-Deiry
Journal:  Mol Cancer Res       Date:  2018-03-27       Impact factor: 5.852

8.  The stress-responsive gene ATF3 regulates the histone acetyltransferase Tip60.

Authors:  Hongmei Cui; Mingxiong Guo; Dong Xu; Zhi-Chun Ding; Gang Zhou; Han-Fei Ding; Junran Zhang; Yi Tang; Chunhong Yan
Journal:  Nat Commun       Date:  2015-04-13       Impact factor: 14.919

9.  Loss of ATF3 promotes Akt activation and prostate cancer development in a Pten knockout mouse model.

Authors:  Z Wang; D Xu; H-F Ding; J Kim; J Zhang; T Hai; C Yan
Journal:  Oncogene       Date:  2014-12-22       Impact factor: 9.867

10.  Loss of SUMOylation on ATF3 inhibits proliferation of prostate cancer cells by modulating CCND1/2 activity.

Authors:  Chiung-Min Wang; Wei-Hsiung Yang
Journal:  Int J Mol Sci       Date:  2013-04-16       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.